Riptide Ventures

Riptide publicly lists five team members — Mike Leffer, Andrew Yanai, Katie Hildreth, Lalita Hamilton, and Leo Liu — but does not designate a CEO, CIO, or managing partner. The firm explicitly states that it makes investment decisions as individuals, which suggests a distributed approval model where each syndicate member can deploy personal capital rather than fund-level committee voting.

Altss research classifies Riptide's strategy as early-stage, spanning Seed, Venture (General), and pre-IPO. The firm's own website uses the language "early stage companies" and positions itself as a vehicle for angel checks rather than growth equity or buyouts, implying a concentration at the seed and Series A portions of the lifecycle.

Riptide's model depends on its member network to source and diligence opportunities. The firm's website frames this as a structural advantage — syndicate members bring distinct relationships that, aggregated, produce a wider funnel than a single GP or small partnership could maintain. No third-party sourcing partnerships or platform relationships are disclosed.

Riptide calls itself a network-powered angel syndicate, not a venture firm. Investment decisions are made by individuals rather than a fund-level investment committee, which distinguishes it from traditional venture partnerships. The firm does not appear to operate a blind-pool fund with external limited partners, though its site includes a "For Investors" section that could accommodate LP-like participation.

The firm's website names consumer, software, and healthcare as its three core sectors. Altss research reinforces that categorization but does not confirm further subsector specificity — such as enterprise SaaS within software or digital health within healthcare — from primary-source evidence.